CBFA2T3-ZNF651, like CBFA2T3-ZNF652, functions as a transcriptional corepressor complex

FEBS Letters

Volumn 584, Issue 5, 2010, Pages 859-864

  Kumar, Raman ^a   Cheney, Kelly M ^b   Neilsen, Paul M ^a   Schulz, Renèe B ^a   Callen, David F ^a  

^a UNIVERSITY OF ADELAIDE   (Australia)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

CBFA2T3; Repressor; ZNF651; ZNF652

Indexed keywords

PROLINE; PROTEIN CBFA2T3; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG; ZINC FINGER PROTEIN 651; ZINC FINGER PROTEIN 652;

ARTICLE; CARBOXY TERMINAL SEQUENCE; CONTROLLED STUDY; DNA BINDING; DNA SEQUENCE; GENE EXPRESSION; GENE REPRESSION; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION;

AMINO ACID SEQUENCE; BASE SEQUENCE; BLOTTING, WESTERN; CELL LINE; DNA-BINDING PROTEINS; ELECTROPHORETIC MOBILITY SHIFT ASSAY; HELA CELLS; HUMANS; IMMUNOPRECIPITATION; MOLECULAR SEQUENCE DATA; PHOSPHOPROTEINS; PROTEIN BINDING; REPRESSOR PROTEINS; SEQUENCE HOMOLOGY, AMINO ACID; TUMOR SUPPRESSOR PROTEINS;

EID: 76749087353     PISSN: 00145793     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.febslet.2010.01.047     Document Type: Article

References (12)

1. Kummerfeld S.K., and Teichmann S.A. DBD: a transcription factor prediction database. Nucleic Acids Res. 34 (2006) D74-D81
2. Fiolka K., Hertzano R., Vassen L., Zeng H., Hermesh O., Avraham K.B., Duhrsen U., and Moroy T. Gfi1 and Gfi1b act equivalently in haematopoiesis, but have distinct, non-overlapping functions in inner ear development. EMBO Rep. 7 (2006) 326-333
3. Hug B.A., and Lazar M.A. ETO interacting proteins. Oncogene 23 (2004) 4270-4274
4. Kumar R., et al. ZNF652, a novel zinc finger protein, interacts with the putative breast tumor suppressor CBFA2T3 to repress transcription. Mol. Cancer Res. 4 (2006) 655-665
5. Kumar R., et al. CBFA2T3-ZNF652 corepressor complex regulates transcription of the E-box gene HEB. J. Biol. Chem. 283 (2008) 19026-19038
6. Kochetkova M., et al. CBFA2T3 (MTG16) is a putative breast tumor suppressor gene from the breast cancer loss of heterozygosity region at 16q24.3. Cancer Res. 62 (2002) 4599-4604
7. Linggi B., and Carpenter G. ErbB-4 s80 intracellular domain abrogates ETO2-dependent transcriptional repression. J. Biol. Chem. 281 (2006) 25373-25380
8. Lausen J., Cho S., Liu S., and Werner M.H. The nuclear receptor co-repressor (N-CoR) utilizes repression domains I and III for interaction and co-repression with ETO. J. Biol. Chem. 279 (2004) 49281-49288
9. Hildebrand D., Tiefenbach J., Heinzel T., Grez M., and Maurer A.B. Multiple regions of ETO cooperate in transcriptional repression. J. Biol. Chem. 276 (2001) 9889-9895
10. Spadaccini R., Perrin H., Bottomley M.J., Ansieau S., and Sattler M. Structure and functional analysis of the MYND domain. J. Mol. Biol. 358 (2006) 498-508
11. Liu Y., et al. Structural basis for recognition of SMRT/N-CoR by the MYND domain and its contribution to AML1/ETO's activity. Cancer Cell 11 (2007) 483-497
12. Kay B.K., Williamson M.P., and Sudol M. The importance of being proline: the interaction of proline-rich motifs in signaling proteins with their cognate domains. FASEB J. 14 (2000) 231-241